Cargando…
Negative Fluid-Attenuated Inversion Recovery-Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
BACKGROUND: Approximately 25% of acute stroke patients were excluded from intravenous thrombolysis using recombinant tissue plasminogen activator (IV-tPA) because of unknown onset time. Recent studies have shown that patients with unknown onset time would be able to receive IV-tPA when showing no is...
Autores principales: | Aoki, Junya, Kimura, Kazumi, Shibazaki, Kensaku, Sakamoto, Yuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776711/ https://www.ncbi.nlm.nih.gov/pubmed/24052793 http://dx.doi.org/10.1159/000348552 |
Ejemplares similares
-
Location of the Susceptibility Vessel Sign on T2*-Weighted MRI and Early Recanalization within 1 Hour after Tissue Plasminogen Activator Administration
por: Aoki, Junya, et al.
Publicado: (2013) -
Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015) -
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014) -
Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset
por: Zhao, Jie, et al.
Publicado: (2019) -
Efficacy and Safety of Intravenous Thrombolysis in Patients with Unknown Onset Stroke: A Meta-Analysis
por: Luan, Di, et al.
Publicado: (2019)